Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases.

Taking Big Steps

Visit our Online Magazine

MorphoSys' mission

MorphoSys mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach.

06/04/2020
MorphoSys Provides Update on Impact of COVID-19 on Business Operations and...
18/03/2020
MorphoSys Presents Results for Fiscal Year 2019
12/03/2020
Invitation to MorphoSys' Year-End Results 2019 Conference Call on...
04/03/2020
MorphoSys Resolves a Capital Increase to Implement the Purchase of 3,629,...
03/03/2020
MorphoSys and Incyte Announce Antitrust Clearance of Global Collaboration...
02/03/2020
FDA Accepts MorphoSys' Biologics License Application (BLA) and Grants...
04/02/2020
MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
13/01/2020
MorphoSys and Incyte Sign Global Collaboration and License Agreement for...
13/01/2020
MorphoSys AG: Ad hoc: MorphoSys and Incyte Sign Global Collaboration and...
30/12/2019
MorphoSys Announces Submission of Biologics License Application for...

March 19, 2020
Conference Call and Webcast
Results Year End 2019
Munich, Germany

Full details